Analystreport

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) had its price target raised by analysts at Barclays PLC from $104.00 to $125.00.

Sarepta Therapeutics, Inc.  (SRPT) 
Last sarepta therapeutics, inc. earnings: 2/26 04:05 pm Check Earnings Report